Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

Related Articles by Review for PubMed (Select 22351604)

1.

PBPK as a tool in regulatory review.

Huang SM.

Biopharm Drug Dispos. 2012 Mar;33(2):51-2. doi: 10.1002/bdd.1777. Review. No abstract available.

PMID:
22351604
2.

Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?

Bouzom F, Ball K, Perdaems N, Walther B.

Biopharm Drug Dispos. 2012 Mar;33(2):55-71. doi: 10.1002/bdd.1767. Epub 2012 Jan 26. Review.

PMID:
22228149
3.

Physiologically based pharmacokinetic (PBPK) modeling in children.

Barrett JS, Della Casa Alberighi O, Läer S, Meibohm B.

Clin Pharmacol Ther. 2012 Jul;92(1):40-9. doi: 10.1038/clpt.2012.64. Epub 2012 Jun 6. Review.

PMID:
22669290
4.

An industrial perspective on contemporary applications of PBPK models in drug discovery and development.

Smith BJ.

Biopharm Drug Dispos. 2012 Mar;33(2):53-4. doi: 10.1002/bdd.1778. Epub 2012 Mar 12. Review. No abstract available.

PMID:
22407480
5.

Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.

Peters SA, Ungell AL, Dolgos H.

Curr Opin Drug Discov Devel. 2009 Jul;12(4):509-18. Review.

PMID:
19562647
6.

Physiologically based pharmacokinetics (PBPK).

Espié P, Tytgat D, Sargentini-Maier ML, Poggesi I, Watelet JB.

Drug Metab Rev. 2009;41(3):391-407. doi: 10.1080/10837450902891360. Review.

PMID:
19601719
7.

A regulatory viewpoint on transporter-based drug interactions.

Zhang L, Zhang YD, Strong JM, Reynolds KS, Huang SM.

Xenobiotica. 2008 Jul;38(7-8):709-24. doi: 10.1080/00498250802017715 . Review.

PMID:
18668428
8.

In vitro measurements of metabolism for application in pharmacokinetic modeling.

Lipscomb JC, Poet TS.

Pharmacol Ther. 2008 Apr;118(1):82-103. doi: 10.1016/j.pharmthera.2008.01.006. Epub 2008 Feb 15. Review.

PMID:
18374419
9.

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development.

Edginton AN, Theil FP, Schmitt W, Willmann S.

Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1143-52. doi: 10.1517/17425255.4.9.1143 . Review.

PMID:
18721109
10.

Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Charnick SB, Kawai R, Nedelman JR, Lemaire M, Niederberger W, Sato H.

J Pharmacokinet Biopharm. 1995 Apr;23(2):217-29. Review.

PMID:
8719238
11.

The role of body-on-a-chip devices in drug and toxicity studies.

Esch MB, King TL, Shuler ML.

Annu Rev Biomed Eng. 2011 Aug 15;13:55-72. doi: 10.1146/annurev-bioeng-071910-124629. Review.

PMID:
21513459
12.

PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism.

Fan J, Chen S, Chow EC, Pang KS.

Curr Drug Metab. 2010 Nov;11(9):743-61. Review.

PMID:
21189137
13.

Integration of physicochemical and pharmacokinetic parameters in lead optimization: a physiological pharmacokinetic model based approach.

Benjamin B, Barman TK, Chaira T, Paliwal JK.

Curr Drug Discov Technol. 2010 Sep;7(3):143-53. Review.

PMID:
20843296
14.

New horizons in pharmaceutical regulation.

Breckenridge A, Mello M, Psaty BM.

Nat Rev Drug Discov. 2012 Jun 29;11(7):501-2. doi: 10.1038/nrd3787. Review.

PMID:
22743964
15.

Biosimilars and regulatory authorities.

Minghetti P, Rocco P, Del Vecchio L, Locatelli F.

Nephron Clin Pract. 2011;117(1):c1-7. doi: 10.1159/000319640. Epub 2010 Aug 3. Review.

16.

Establishing efficacy of human products using animals: the US food and drug administration's "animal rule".

Snoy PJ.

Vet Pathol. 2010 Sep;47(5):774-8. doi: 10.1177/0300985810372506. Epub 2010 Jun 15. Review.

17.

Property-based design: optimization of drug absorption and pharmacokinetics.

van De Waterbeemd H, Smith DA, Beaumont K, Walker DK.

J Med Chem. 2001 Apr 26;44(9):1313-33. Review. No abstract available.

PMID:
11311053
18.

Physiological basis of multicompartmental models of drug distribution.

Atkinson AJ Jr, Ruo TI, Frederiksen MC.

Trends Pharmacol Sci. 1991 Mar;12(3):96-101. Review.

PMID:
2053193
19.

European regulatory guidelines for biosimilars.

Wiecek A, Mikhail A.

Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v17-20. Review.

20.

Role of pharmacokinetics and metabolism in drug discovery and development.

Lin JH, Lu AY.

Pharmacol Rev. 1997 Dec;49(4):403-49. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk